For this Abbott executive, solving problems isn’t enough: ‘We need to add value’


Abbott's Michael PedersonAs payers and providers across healthcare shift their focus to value-based care, leaders in the medical device industry are racing to keep up. Michael Pederson, SVP of cardiac arrhythmias and heart failure at Abbott, told why simply solving problems with new technology isn’t enough anymore.

What was your path like from electrical engineering to Abbott’s cardiac arrhythmia business?
Pederson: As an engineer, I’ve always been drawn to how technology can evolve and re-shape entire industries. In particular, health technology can fundamentally change the lives of people battling complex health conditions. Seeing new therapies or diagnostic tools go from the earliest stages of research and design and evolving into the products physicians and hospitals deploy to positively change the course of someone’s life never stops inspiring me.

Get the full story at

Hear Pederson talk about the future of cardiovascular tech at DeviceTalks Minnesota, June 4–5 in St. Paul.

Inside Hologic's evolving definition of women's healthcare

textadimage Steve MacMillan took over as CEO of Hologic in 2013, drawing on his experience at medtech titans like Stryker and Johnson & Johnson. Since then, Hologic has grown into a $3 billion business.

At DeviceTalks Boston, MacMillan will provide exclusive insights into the Massachusetts-based company and its evolving definition of women's healthcare. You don't want to miss it!


Use code WOMENSHEALTH to save an additional 10%.

Speak Your Mind